title: Postmenopausal dyspareunia: has the Food and Drug Administration really helped?
authors.forename: Steven R
authors.initials: SR
authors.lastname: Goldstein
mesh_terms: D004414:Dyspareunia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D017698:Postmenopause; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage*; D013629:Tamoxifen / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014844:Vulva / Q000473:pathology*
chemical_list: D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; C119141:Ospemifene